- Health oversight agencies anticipate that, during the next decade, a growing number of people living into old age will increase the need for caregiver services for patients with a decline in cognitive function and an increase in confusion
- California-based MetAlert is a pioneer in developing wearable, unobtrusive technology that helps caregivers track the whereabouts of patients with cognitive decline and who may be prone to becoming lost if they wander
- The company is also preparing to roll out an expansion of its flagship product that will have the capacity to serve as a tech hub for its product as well as other wearable health monitoring devices with which it can communicate to collect their data for medical services
- Such devices can help eliminate the need for patients to routinely visit medical offices to monitor their health data, where they may risk exposure to other people who may endanger their health, as was made clear during the height of the COVID pandemic
Last fall, the newest report on age and health of the World Health Organization (“WHO”) stated that the number of people aged 60 years and older outnumbered children younger than 5 years in 2020 and projected that between 2015 and 2050, the proportion of the world’s population over 60 years will nearly double from 12 percent to 22 percent (https://ibn.fm/16leG).
The growth of the population of people entering into old age, and the rising ratio of older populations to younger caregiving generations, has taken on new importance for societies working to manage…
NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.